|
Market Closed -
NYSE
04:00:03 2026-09-01 pm EDT
|
5-day change | 1st Jan Change | ||
| 162.47 USD | +0.21% |
|
-4.24% | +76.73% |
| 06:49am | AstraZeneca PLC : Deutsche Bank reiterates its Sell rating | ZD |
| 02:43am | AstraZeneca finalizes the acquisition of global rights to Zegfrovy |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
- Consensus AstraZeneca PLC
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
